Fundamental leadership · SEC EDGAR · no analyst estimates · as of 2026-09-10
Which industries lead on earnings and sales, today. As of 2026-09-10, 4,465 companies clear the eligibility gates and 1,340 rank Leader or Strong on filed EPS and revenue growth. The strongest industry group is Precious Metals with 29 Leader or Strong names. 19.9% of eligible companies also sit in the top relative-strength quintile — fundamentals and price agreeing.
Industry / Healthcare
| Ticker | Company | Rank | Δ3wk | Verdict | EPS YoY | Sales YoY | Margin Δ | 6M RS | Filed |
|---|---|---|---|---|---|---|---|---|---|
| BLLN | BillionToOne, Inc. Class A Common Stock | 98 | ±0 | Leader | to profit↑ | +64%↓ | — | 90 | 2026-08-05 |
| NIVF | NewGenIvf Group Limited Class A ordinary shares | 98 | -1 | Leader | to profit | >+999% | — | 2 | 2026-03-31 |
| CDNA | CareDx, Inc. | 96 | ±0 | Leader33 | to profit↑ | +52%↑ | +1196 bps | 98 | 2026-07-30 |
| CAI | Caris Life Sciences, Inc. Common Stock | 95 | ±0 | Leader | to profit | +45%↓ | +5592 bps | 82 | 2026-08-05 |
| OMDA | Omada Health, Inc. Common Stock | 95 | ±0 | Leader33 | to profit↑ | +43%↑ | +1526 bps | 92 | 2026-08-07 |
| BTSG | BrightSpring Health Services, Inc. Common Stock | 94 | ±0 | Leader | +192% | +23% | +115 bps | 87 | 2026-07-31 |
| VCYT | Veracyte, Inc.Genomics & Precision-Medicine Tools | 94 | ±0 | Leader | to profit | +15% | +1594 bps | 82 | 2026-07-31 |
| INNV | InnovAge Holding Corp. Common Stock | 93 | +58 | Leader | >+999% | +18%↑ | +375 bps | 78 | new filing |
| LFST | LifeStance Health Group, Inc. Common Stock | 93 | ±0 | Leader | to profit | +26%↑ | +497 bps | 96 | 2026-08-06 |
| PRVA | Privia Health Group, Inc. Common Stock | 90 | ±0 | Leader | +250% | +21% | +87 bps | 39 | 2026-08-06 |
| AVAH | Aveanna Healthcare Holdings Inc. Common Stock | 88 | ±0 | Strong | +38% | +14%↓ | +312 bps | 96 | 2026-08-13 |
| PACS | PACS Group, Inc. | 87 | ±0 | Strong | +52% | +9%↓ | +275 bps | 83 | 2026-08-04 |
| AGL | agilon health, inc. | 86 | -1 | Strong | to profit↑ | +7% | +121 bps | 99 | 2026-08-05 |
| PNTG | The Pennant Group, Inc. Common Stock | 84 | ±0 | Strong | +25% | +36%↓ | +11 bps | 69 | 2026-08-05 |
| SHC | Sotera Health Company Common Stock | 83 | ±0 | Strong | +533%↑ | +9% | +644 bps | 83 | 2026-08-06 |
| CCM | Concord Medical Services Holding Limited | 79 | ±0 | Strong | loss narrowed 70% | +21% | +8451 bps | 69 | 2026-04-29 |
| GRAL | GRAIL, Inc. Common Stock | 79 | ±0 | Strong | loss narrowed 19% | +26% | >+10,000 bps | 93 | 2026-08-06 |
| STLN | Starling Oncology, Inc. Common Stock | 79 | — | Strong | loss narrowed 47% | +35%↓ | +661 bps | — | 2026-08-06 |
| NTRA | Natera, Inc. Common StockGenomics & Precision-Medicine Tools | 78 | ±0 | Strong | loss narrowed 36% | +38%↓ | +425 bps | 93 | 2026-08-07 |
| SRTA | Strata Critical Medical, Inc. Class A Common Stock | 76 | ±0 | Strong | loss widened 140% | +2% | +102 bps | 62 | 2026-08-04 |
| THC | Tenet Healthcare Corporation New | 73 | -1 | Strong | +213%↑ | +7% | +304 bps | 66 | 2026-07-29 |
| SBC | SBC Medical Group Holdings Incorporated Common Stock | 72 | ±0 | Strong | +400% | +13%↑ | -2114 bps | 74 | 2026-08-13 |
| ENSG | The Ensign Group, Inc. | 71 | ±0 | Strong | +17% | +17%↓ | -1 bps | 27 | 2026-07-27 |
| XGN | Exagen Inc. Common Stock | 71 | ±0 | Strong | loss narrowed 38%↑ | +16% | +528 bps | 97 | 2026-08-04 |
| NHC | National Healthcare Corp. | 70 | ±0 | Strong | +67% | +4% | +172 bps | 89 | 2026-08-06 |
| VMD | Viemed Healthcare, Inc. Common Shares | 70 | ±0 | Strong | -12%↓ | +24% | -117 bps | 44 | 2026-08-03 |
| GH | Guardant Health, Inc. Common StockGenomics & Precision-Medicine Tools | 69 | ±0 | Average | loss widened 12% | +44% | +1584 bps | 95 | 2026-07-30 |
| PGNY | Progyny, Inc. Common Stock | 67 | ±0 | Average | +79%↑ | +5% | +237 bps | 92 | 2026-08-07 |
| CHE | Chemed Corporation | 66 | ±0 | Average | +44%↑ | +9% | -438 bps | 81 | 2026-07-31 |
| HCSG | Healthcare Services Group | 66 | -1 | Average | to profit | +3%↓ | +724 bps | 62 | 2026-07-24 |
| ADUS | Addus HomeCare Corp. | 64 | ±0 | Average | +24% | +8% | +91 bps | 69 | 2026-08-04 |
| CON | Concentra Group Holdings Parent, Inc. | 63 | ±0 | Average | +46% | +10%↓ | +68 bps | 91 | 2026-08-06 |
| DVA | DaVita Inc. | 62 | ±0 | Average | +56%↑ | +5%↓ | -59 bps | 71 | 2026-08-04 |
| FMS | Fresenius Medical Care AG | 62 | ±0 | Average | +414%↑ | -4% | +260 bps | 46 | 2026-02-24 |
| UHS | Universal Health Services, Inc. Class B | 62 | ±0 | Average | +10%↓ | +8% | +36 bps | 39 | 2026-08-07 |
| EHC | Encompass Health Corporation Common Stock | 61 | -1 | Average | +11% | +10% | +50 bps | 75 | 2026-08-07 |
| MDXH | MDxHealth SA Ordinary Shares | 57 | ±0 | Average | loss narrowed 42% | +20% | +1410 bps | 4 | 2026-04-03 |
| HCA | HCA Healthcare, Inc. | 56 | ±0 | Average | +11% | +4%↓ | +80 bps | 24 | 2026-07-28 |
| BKD | Brookdale Senior Living, Inc. | 55 | ±0 | Average | to profit↑ | -12%↓ | +183 bps | 30 | 2026-08-10 |
| MGRX | Mangoceuticals, Inc. Common Stock | 53 | ±0 | Average | loss narrowed 84% | -59%↓ | — | 49 | 2026-08-13 |
| OPCH | Option Care Health, Inc. Common Stock | 53 | -1 | Average | +4% | +1% | -67 bps | 25 | 2026-07-29 |
| MD | Pediatrix Medical Group, Inc. | 50 | -1 | Average | +7% | +4%↑ | +254 bps | 85 | 2026-08-04 |
| CSTL | Castle Biosciences, Inc. Common Stock | 49 | -1 | Average | to loss | +20% | -233 bps | 78 | 2026-07-30 |
| DGX | Quest Diagnostics Inc. | 49 | ±0 | Average | +15% | +10%↑ | +8 bps | 69 | 2026-07-23 |
| SNDA | Sonida Senior Living, Inc. | 47 | ±0 | Average | loss widened 225%↓ | +122%↑ | -4944 bps | 72 | 2026-08-10 |
| EUDA | EUDA Health Holdings Limited Ordinary Shares | 44 | — | Average | loss widened 215% | +70% | — | 27 | 2026-04-28 |
| RDNT | RadNet, Inc. Common Stock | 44 | ±0 | Average | -47% | +25%↑ | -30 bps | 76 | 2026-08-10 |
| HIMS | Hims & Hers Health, Inc.Obesity & Weight-Loss Therapeutics | 43 | ±0 | Average | to loss↓ | +38% | -1223 bps | 58 | 2026-08-10 |
| LH | Labcorp Holdings Inc. | 40 | -1 | Average | +28% | +6%↑ | +160 bps | 67 | 2026-08-05 |
| AMS | American Shared Hospital Services | 39 | -1 | Average | loss widened 75%↓ | +19%↑ | +383 bps | 18 | 2026-08-13 |
| TDOC | Teladoc Health, Inc. | 37 | ±0 | Average | loss widened 11%↓ | -4%↓ | +302 bps | 65 | 2026-07-30 |
| BDSX | Biodesix, Inc. Common Stock | 36 | ±0 | Average | loss widened 787%↑ | +34% | +2452 bps | 86 | 2026-08-05 |
| ACON | Aclarion, Inc. Common Stock | 34 | -1 | Average | loss narrowed 59%↓ | +30% | — | 21 | 2026-08-06 |
| BRTX | BioRestorative Therapies, Inc. Common Stock (NV) | 34 | -1 | Average | loss narrowed 81%↑ | -7%↑ | — | 10 | 2026-05-14 |
| PIII | P3 Health Partners Inc. Common Stock | 33 | -1 | Average | loss narrowed 90% | +9% | +1184 bps | 98 | 2026-08-10 |
| USPH | US Physical Therapy Inc | 30 | ±0 | Average | -57%↑ | +8% | -70 bps | 45 | 2026-08-07 |
| WGS | GeneDx Holdings Corp. Class A Common Stock | 29 | ±0 | Laggard | to loss | +11%↓ | -2184 bps | 47 | 2026-08-03 |
| YDES | YD Bio Limited Ordinary Shares | 28 | ±0 | Laggard | loss widened 500% | +17% | — | 10 | 2026-04-30 |
| ARDT | Ardent Health, Inc. | 26 | ±0 | Laggard | -77% | -1% | -354 bps | 75 | 2026-08-10 |
| PSNL | Personalis, Inc. Common StockGenomics & Precision-Medicine Tools | 24 | -1 | Laggard | loss widened 30% | +30% | -7444 bps | 96 | 2026-08-04 |
| SERA | Sera Prognostics, Inc. Class A Common Stock | 24 | ±0 | Laggard | loss widened 12%↓ | +76% | — | 59 | 2026-08-12 |
| AIRS | AirSculpt Technologies, Inc. Common Stock | 21 | ±0 | Laggard | loss widened 100%↓ | -3% | -311 bps | 59 | 2026-08-10 |
| CCEL | Cryo-Cell International Inc. | 20 | ±0 | Laggard | +75%↑ | -2% | -1226 bps | 82 | 2026-07-15 |
| SGRY | Surgery Partners, Inc. Common Stock | 20 | ±0 | Laggard | loss widened 500%↓ | +3% | +23 bps | 57 | 2026-08-10 |
| FTRE | Fortrea Holdings Inc. Common Stock | 18 | ±0 | Laggard | loss narrowed 97%↑ | -5% | +3340 bps | 95 | 2026-07-29 |
| ACHC | Acadia Healthcare Company, Inc. | 17 | ±0 | Laggard | -44% | +8%↑ | -3982 bps | 74 | 2026-07-28 |
| FLGT | Fulgent Genetics, Inc. Common Stock | 15 | ±0 | Laggard | loss widened 69%↑ | +4% | -1377 bps | 87 | 2026-07-30 |
| CYH | Community Health Systems, Inc. | 13 | ±0 | Laggard | -76% | -10%↓ | +449 bps | 36 | 2026-07-23 |
| AHCO | AdaptHealth Corp. Common Stock | 11 | ±0 | Laggard | to loss | -8% | -1259 bps | 13 | 2026-08-04 |
| DCGO | DocGo Inc. Common Stock | 7 | -1 | Laggard | loss widened 45%↑ | -9%↑ | -5555 bps | 12 | 2026-08-17 |
| LFMD | LifeMD, Inc. Common Stock | 6 | ±0 | Laggard | loss widened 220% | -25% | -1344 bps | 22 | 2026-08-05 |
| BGLC | BioNexus Gene Lab Corp Common stock | 2 | ±0 | Laggard | loss narrowed 66% | -97% | — | 13 | 2026-08-14 |
| ATPC | Agape ATP Corporation Common Stock | 1 | ±0 | Laggard | to profit↑ | -97%↓ | — | 12 | 2026-08-14 |
Every US common stock and ADR in the universe is ranked on fundamental growth from the numbers companies actually filed with the SEC — no analyst estimates, no forward projections. TickerStance reads EDGAR XBRL company facts directly.
To qualify, a company must have at least six quarters of EPS and revenue history available and the most-recent filing must be no older than 200 days. That gate keeps the rankings grounded in current operating conditions rather than stale data.
Two growth factors are computed: recent year-over-year growth (latest quarter vs the same quarter last year) blended with a three-year trend score. Both factors are percentile-ranked universe-wide so a rank of 90 means the company grows faster than 90% of its peers, regardless of absolute size. The two factor percentiles are then combined into a single 1-99 fundamentals rank.
Operating margin is tracked as context — a company whose margins are expanding while growing revenue is a stronger story than one shrinking margins to buy growth — but margin level is not a direct rank input. Industries, sectors, and themes inherit their rank from the median of their members, so a strong cluster is one where most constituent companies score well, not just a few outliers.
The RS overlap metric shows what share of a cluster's eligible companies sit in the top relative-strength quintile (6M RS rank ≥ 80). When a fundamentally strong group also carries broad price leadership, it has both the earnings story and the institutional sponsorship — the combination that historically precedes sustained outperformance.
Every US common stock and ADR with sufficient SEC filing history gets a 1-99 fundamentals rank: EPS and revenue growth factors are computed from filed XBRL data, percentile-ranked across the universe, and blended. Ranks of 90+ are Leaders, 70-89 Strong, 30-69 Average, below 30 Laggards. Industries, sectors, and themes are then ranked by their members' median rank.
SEC EDGAR XBRL company facts — the numbers companies actually filed. No analyst estimates, no forward guidance, no third-party data vendor.
Sign-aware: a narrowed loss counts as improvement, a widened loss as deterioration, a swing to profit as a turnaround. Conventional percent math misreads losses (a loss shrinking from -$0.12 to -$0.07 is improvement, not "down 42%"), so the table says "loss narrowed 42%" instead of printing a misleading percentage.
The change in a group's median fundamentals rank versus 15 and 30 trading days ago — the classic "improving group" read. Positive means the group is gaining rank. Dashes mean the history window isn't available yet.
Once per US trading day after the close. The as-of date in the header is the snapshot date.